Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dexrazoxane |
Is a |
True |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium phytate |
Is a |
True |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alcohol dehydrogenase inhibitor |
Is a |
True |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ipecacuanha (substance) |
Is a |
True |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Substance with cholinesterase reactivator mechanism of action |
Is a |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Protamine (substance) |
Is a |
True |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antidotes for pesticides |
Is a |
True |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Substance with opioid receptor antagonist mechanism of action (substance) |
Is a |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Heavy metal antagonist (substance) |
Is a |
True |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Anti-heparin agent |
Is a |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Substance with benzodiazepine receptor antagonist mechanism of action (substance) |
Is a |
True |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ion exchange resin |
Is a |
True |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mercaptamine |
Is a |
True |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Opiate antagonist poisoning NOS |
Causative agent (attribute) |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antidote poisoning |
Causative agent (attribute) |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Antidote adverse reaction |
Causative agent (attribute) |
True |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Charcoal activated adverse reaction |
Causative agent (attribute) |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium nitrite adverse reaction |
Causative agent (attribute) |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium thiosulfate adverse reaction |
Causative agent (attribute) |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Digoxin specific antibody adverse reaction |
Causative agent (attribute) |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrofluoric acid burn antidote adverse reaction |
Causative agent (attribute) |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to antidote |
Causative agent (attribute) |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to activated charcoal |
Causative agent (attribute) |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to sodium nitrite |
Causative agent (attribute) |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium thiosulfate allergy |
Causative agent (attribute) |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to digoxin immune fab (finding) |
Causative agent (attribute) |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrofluoric acid burn antidote allergy |
Causative agent (attribute) |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antidote overdose (disorder) |
Causative agent (attribute) |
True |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de sulfate de protamine |
Causative agent (attribute) |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
surdose accidentelle de sulfate de protamine |
Causative agent (attribute) |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
surdose intentionnelle de sulfate de protamine |
Causative agent (attribute) |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
surdose de sulfate de protamine d'intention indéterminée |
Causative agent (attribute) |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesna |
Is a |
True |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing methionine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Activated charcoal oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fuller's earth-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fuller's earth powder (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
acide édétique en sel dicobaltique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
édétate dicobaltique 15 mg/mL, ampoule de 20 mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium nitrite-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium nitrite 300mg/10mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium thiosulfate 12.5g/25mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium calciumedetate 1g/5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sodium calcium edetate 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing digoxin immune fab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methionine 100 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol+methionine 500mg/250mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Apomorphine hydrochloride 20mg/2mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Apomorphine hydrochloride 50mg/5mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
chlorhydrate d'apomorphine 30 mg/3 mL, stylo-injecteur prérempli |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Drugs used in the treatment of paracetamol poisoning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
acétylcystéine 200 mg/mL, ampoule de 10 mL pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methionine 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trisodium edetate (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trisodium edetate 200mg/mL injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Deferiprone (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Deferiprone 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Disodium edetate 0.37% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chelating agents and antidotes (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing chelating agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Edetate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrofluoric acid burn antidote |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Activated charcoal 5g/sachet granules (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Activated charcoal powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antidotes for pesticides (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bentonite powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyanide antidote |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polyvalent crotalidae antivenom-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polyvalent snake antivenin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ammonia detoxicant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium thiosulfate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing Micrurus fulvius antivenom (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing apomorphine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Snake antivenom immunoglobulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing edetate disodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medicinal product acting as emetic agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medicinal product acting as antidote agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Emetics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medicinal product acting as adsorbent agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyanide poisoning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Heavy metal poisoning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Organophosphorus poisoning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iron poisoning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Apomorphine hydrochloride [erectile dysfunction] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Apomorphine hydrochloride 2 mg sublingual tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely apomorphine hydrochloride 3 milligram/1 each conventional release sublingual tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
médicaments utilisés pour traiter l'hyperuricémie |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing rasburicase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rasburicase 1.5mg powder and solvent for infusion vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing potassium iodate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium iodate 85 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Calcium 667mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Digoxin specific antibody 38mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing activated charcoal (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing methionine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Edetate disodium anhydrous 150mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chlorhexidine gluconate+sodium nitrite 0.5/0.1% in 70% IMS solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adverse reaction to emetics NOS |
Causative agent (attribute) |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rasburicase 7.5mg infusion (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium thiosulfate 12.5g/50mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antidote |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|